UNSPSC 51451803: Nitrodan

This classification denotes an antihelminthic agent with the molecular formula C10H8N4O3S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2STG09LA8F, chemically known as rhodanine, 3-methyl-5-(p-nitrophenylazo)- but generally known as nitrodan, which bears US NIH Compound Identifier 13752. European Medicines Agency schedules Nitrodan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09324MIG. The term NITRODAN is an International Non-Proprietary Name.

UNSPSC 51451803 Nitrodan is a Commodity code under which state and local governments procure pharmaceutical products and related medical supplies, including antibiotics, opioid antagonists, and drug deactivation systems. Recent solicitations show purchasing activity centered on antibiotics for emergency preparedness and public health response, as well as naloxone and drug disposal systems for community health programs. State and local issuing bodies include state departments of public health, county health agencies, and special-purpose districts leveraging cooperative purchasing vehicles such as MMCAP Infuse consortiums to aggregate demand and secure volume pricing on pharmaceutical inventory.

Activity under the code spans Illinois and Florida in recent records. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026 through MMCAP Infuse for supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under an IFB process, with a 12-month initial term and two renewal options. Seminole County, Florida issued an IFB on June 30, 2026 (due July 26, 2023) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building; the contract carried a two-year initial term with one-year renewal option, fixed-fee pricing, and potential FEMA funding with associated federal compliance requirements including E-Verify and drug-free workplace certification.